沙特阿拉伯王国政府所属的官方政府网站。
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
在数字政府管理局注册,编号:
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
Ensure the website is using the HTTPS protocol.
在数字政府管理局注册,编号:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Insulin Degludec,Liraglutide | Xultophy | 4.8 Undesirable effects | Jul, 2024 |
| Fluvastatin | Lescol XL | 4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects | Feb,2023 |
| Rosuvastatin | Crestor | 4.4 Special Warnings and Special Precautions for Use , 4.8 Undesirable effects | Feb,2023 |
| Semaglutide | Rybelsus | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Insulin Glargine/Lixisenatide | Soliqua Solostar | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Tobramycin Inhalation Solution | Tobi Podhaler | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Belimumab | Benlysta | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
| Cadribine | Mavenclad | 4.5. Interactions with other medicinal products | Feb,2023 |
| Phenytoin Sodium | Epanutin | 4.4 Special warnings and precautions for use | Feb, 2025 |
| Fluvastatin | Lescol Xl | 4.4 Special Warnings and Special Precautions for Use | Dec,2023 |
最后更新日期: 13/08/2026 at 02:25 下午 Saudi Arabia time
此页面尚未收到任何反馈。
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。